A Gynecologic Oncology Group Study of serum CA-125 levels in patients with stage III optimally debulked ovarian cancer treated with intraperitoneal compared to intravenous chemotherapy: An analysis of patients enrolled in GOG 172-Reference-Cited by-同舟云学术

A Gynecologic Oncology Group Study of serum CA-125 levels in patients with stage III optimally debulked ovarian cancer treated with intraperitoneal compared to intravenous chemotherapy: An analysis of patients enrolled in GOG 172

Published:2009-10 Issue:1 Volume:115 Page:81-85
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Krivak Thomas C.,Tian Chunqiao,Rose G. Scott,Armstrong Deborah K.,Maxwell G. Larry

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference26 articles.

1. Cancer Statistics, 2008;Jemal;CA Cancer J. Clin.,2008

2. Use of CA-1225 to predict survival of patients with ovarian carcinoma. North Thames Cooperative Group;Rustin;J. Clin. Oncol.,1989

3. Defining response of ovarian carcinoma to initial chemotherapy according to serum CA125;Rustin;J. Clin. Oncol.,1996

4. Significance of early changes in the serum Ca-125 antigen level on overall survival in advanced ovarian cancer;Markman;Gynecol. Oncol.,2006

5. Intraperitoneal cisplatin and paclitaxel in ovarian cancer;Armstrong;N. Engl. J. Med.,2006

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Elevated Serum Tumor Markers (HE4 and ROMA Score) and Increased Treg Cells Distinguished Ovarian Cancer and Benign Tumor;The Indonesian Biomedical Journal;2024-06-26

2. Preoperative and pre-chemotherapy CA-125 levels in high-risk early-stage ovarian cancer – An NRG/GOG study;Gynecologic Oncology;2024-02

3. Prognostic Significance of CA125 Dynamic Change for Progression Free Survival in Patients with Epithelial Ovarian Carcinoma;Medical Science Monitor;2020-07-14

4. Prediction of survival outcomes in patients with epithelial ovarian cancer using machine learning methods;Journal of Gynecologic Oncology;2019

5. Application of CAR T cells for the treatment of solid tumors;Progress in Molecular Biology and Translational Science;2019